Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 87 citing articles:

Wnt/β-catenin signaling in cancers and targeted therapies
Fanyuan Yu, Changhao Yu, Feifei Li, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 416
The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer
Zimei Yang, Qiuhua Zhang, Linghong Yu, et al.
Journal of Ethnopharmacology (2020) Vol. 264, pp. 113249-113249
Closed Access | Times Cited: 173
Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming
Jinmei Jin, Shui-Ping Qiu, Ping Wang, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 172
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Minru Liao, Rui Qin, Wei Huang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 95
Hydroxysafflor yellow A: a natural pigment with potential anticancer therapeutic effect
Yuhan Wang, Junsha An, Jianbo Zhou, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 2
Targeting Cancer with Phytochemicals via Their Fine Tuning of the Cell Survival Signaling Pathways
Salvatore Chirumbolo, Geir Bjørklund, Roman Lysiuk, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3568-3568
Open Access | Times Cited: 97
The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
Elizabeth Varghese, Samson Mathews Samuel, Mariam Abotaleb, et al.
Cancers (2018) Vol. 10, Iss. 10, pp. 346-346
Open Access | Times Cited: 95
Cardamonin: A new player to fight cancer via multiple cancer signaling pathways
Javaria Nawaz, Azhar Rasul, Muhammad Ajmal Shah, et al.
Life Sciences (2020) Vol. 250, pp. 117591-117591
Closed Access | Times Cited: 79
Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer
Amr Ahmed WalyEldeen, Salwa Sabet, Haidan M. El-Shorbagy, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110297-110297
Closed Access | Times Cited: 59
Cardamonin-loaded liposomal formulation for improving percutaneous penetration and follicular delivery for androgenetic alopecia
Zhenda Liu, Zehui He, Xinyi Ai, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 9, pp. 2444-2460
Closed Access | Times Cited: 10
Molecular Mechanisms of Antiproliferative Effects of Natural Chalcones
Radka Michalková, Ladislav Mirossay, Maria Gazdova, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2730-2730
Open Access | Times Cited: 46
Anticancer Potential of Natural Chalcones: In Vitro and In Vivo Evidence
Radka Michalková, Ladislav Mirossay, Martin Kello, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10354-10354
Open Access | Times Cited: 20
Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway
Xiaoshu Zhou, Rui Zhou, Qianwen Li, et al.
Anti-Cancer Drugs (2019) Vol. 30, Iss. 3, pp. 241-250
Closed Access | Times Cited: 52
Cardamonin induces G2/M arrest and apoptosis via activation of the JNK–FOXO3a pathway in breast cancer cells
Weiwei Kong, Chuang Li, Qiaofang Qi, et al.
Cell Biology International (2019) Vol. 44, Iss. 1, pp. 177-188
Closed Access | Times Cited: 43
Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
Citra Dewi, Adryan Fristiohady, Riezki Amalia, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3661-3661
Open Access | Times Cited: 24
Protective Effect of Natural Antioxidants on Reducing Cisplatin-Induced Nephrotoxicity
Jie Zhou, Run‐Cong Nie, Yixin Yin, et al.
Disease Markers (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 24
Cardamonin induces ROS-mediated G2/M phase arrest and apoptosis through inhibition of NF-κB pathway in nasopharyngeal carcinoma
Yuting Li, You Qin, Chensu Yang, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 8, pp. e3024-e3024
Open Access | Times Cited: 48
Cardamonin inhibits colonic neoplasia through modulation of MicroRNA expression
Shirley James, Jayasekharan S. Aparna, Aswathy Mary Paul, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 47
S100A4 promotes lung tumor development through β-catenin pathway-mediated autophagy inhibition
Shasha Hou, Tian Tian, Dianwen Qi, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 3
Open Access | Times Cited: 45
Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer
Dana Elkhalifa, Abu Bakar Siddique, Mohammed H. Qusa, et al.
European Journal of Medicinal Chemistry (2019) Vol. 187, pp. 111954-111954
Closed Access | Times Cited: 40
NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway
Qiao Zheng, Dejiao Yao, Yi Cai, et al.
Bioscience Reports (2020) Vol. 40, Iss. 7
Open Access | Times Cited: 38
Recent progress in small molecule agents for the targeted therapy of triple-negative breast cancer
Rajibul Islam, Kok Wai Lam
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112812-112812
Closed Access | Times Cited: 37
Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases
Uzini Devi Daimary, Parama Dey, Varsha Rana, et al.
Current Research in Pharmacology and Drug Discovery (2020) Vol. 2, pp. 100008-100008
Open Access | Times Cited: 35
Small Molecule Wnt Pathway Modulators from Natural Sources: History, State of the Art and Perspectives
Artem Blagodatski, Antonina Klimenko, Lee Jia, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 589-589
Open Access | Times Cited: 33
Current report of natural product development against breast cancer stem cells
Adam Hermawan, Herwandhani Putri
The International Journal of Biochemistry & Cell Biology (2018) Vol. 104, pp. 114-132
Closed Access | Times Cited: 35
Page 1 - Next Page

Scroll to top